The US-based Novavax Covid vaccine is 90.4 percent effective, according to the company.
Approximately 29,960 people tested in the United States and Mexico have been confirmed to be 100 percent protected from moderate to severe disease.
“The vaccine is easy to stockpile and carry,” NovaVax said in a statement.
We will get approval in the third quarter of 2021. It is expected to produce 100 million doses per month by the end of the quarter and 15 million doses per month by the end of the year.
In the United States, three vaccines, Pfizer, Moderna, Johnson & Johnson, are being used as an emergency measure. As a result, the demand for the vaccine in the United States has plummeted.
Therefore, it has reportedly decided to sell it to developing countries after obtaining approval from the US Department of Drug Control.Leave a comment